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REVIEW
Male sexual dysfunction and infertility associated with
neurological disorders
Mikkel Fode1, Sheila Krogh-Jespersen2, Nancy L Brackett3, Dana A Ohl4, Charles M Lynne5 and Jens Sønksen1
Normal sexual and reproductive functions depend largely on neurological mechanisms. Neurological defects in men can cause
infertility through erectile dysfunction, ejaculatory dysfunction and semen abnormalities. Among the major conditions contributing to
these symptoms are pelvic and retroperitoneal surgery, diabetes, congenital spinal abnormalities, multiple sclerosis and spinal cord
injury. Erectile dysfunction can be managed by an increasingly invasive range of treatments including medications, injection therapy
and the surgical insertion of a penile implant. Retrograde ejaculation is managed bymedications to reverse the condition in mild cases
and in bladder harvest of semen after ejaculation in more severe cases. Anejaculation might also be managed by medication in mild
cases while assisted ejaculatory techniques including penile vibratory stimulation and electroejaculation are used in more severe
cases. If these measures fail, surgical sperm retrieval can be attempted. Ejaculation with penile vibratory stimulation can be done by
some spinal cord injured men and their partners at home, followed by in-home insemination if circumstances and sperm quality are
adequate. The other options always require assisted reproductive techniques including intrauterine insemination or in vitro fertilization
with or without intracytoplasmic sperm injection. The method of choice depends largely on the number of motile sperm in the
ejaculate.
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INTRODUCTION
Male reproductive functioning is highly dependent on the neuro-
logical integrity of the pelvic floor and the spinal cord. Erectile func-
tion and ejaculation are diminished in patients with neurological
damage from conditions including spinal cord injury (SCI), diabetes
mellitus, multiple sclerosis (MS), congenital disorders of the spinal
cord and trauma or surgery. Furthermore, neurological problems can
cause impairments in sperm quality, which is most often seen in spinal
cord-injured men.
Normal erectile function
Erections are initiated by a combination of psychic and physical stim-
uli, and erectile function is controlled by parasympathetic fibers ori-
ginating from S2 to S4. These fibers travel through the pelvic nerve and
the pelvic plexus to the cavernous nerve, which enters the corpora
cavernosa.1 As these fibers pass through the pelvis, the nerves run in
close proximity to the prostate and rectum, which makes them prone
to injury during surgical procedures. When activated, the cavernous
nerves release nitric oxide and acetylcholine, both of which induce
relaxation of the smooth muscle tissue by inducing cyclic guanosine
monophosphate and cyclic adenosine monophosphate, respectively,
which in turn results in calcium efflux. This process causes a massive
influx of blood to the tissue. Through a shear stress mechanism
induced by this blood flow, the endothelium in the penis releasesmore
nitric oxide that causes an erection to reach a maximum and then
maintains that erection.2 Increased intracavernosal pressure then
compresses the small venules, which results in blood trapping and
contributes to maintaining the erection. The activation of basic sym-
pathetic tone following sexual activity results in the contraction of
smooth muscle, which results in the penis returning to a flaccid state.
Moreover, phosphodiesterase 5 (PDE5), which is abundant in the
penile tissue, contributes to this process by breaking down cyclic gua-
nosine monophosphate.
Ejaculatory function
Like erection, ejaculation is the result of coordination of both psycho-
logical and physical sexual stimulation. The ejaculatory reflex is
coordinated by the spinal cord and depends on thoracolumbar sym-
pathetic fibers from segments T10–L2 and somatic fibers from seg-
ments S2–S4. This reflex receives its somatic input primarily from the
dorsal nerve of the penis, which is activated by stimulation of the glans
penis. Neurons in the cortex, thalamus, hypothalamus, midbrain and
pons, all play a role in ejaculation; however, their exact functions are
poorly understood.3,4
Prior to ejaculation, sperm that are stored in the epididymis are
transported to the vas deferens by means of contractions of smooth
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muscle tissue. This is followed by coordinated contractions of the vas
mediated by the sympathetic fibers.5 The contractions move sperm
through the vas to the ejaculatory ducts, which also have an inlet from
the seminal vesicles.6 Along with seminal plasma from the seminal
vesicles and prostate, the sperm are then transported to the urethra
from which they are expelled in a projectile manner as somatic nerve
fibers induce rhythmic contractions of the pelvic/periurethral mus-
cles. During ejaculation, the bladder neck closes and the external
urethral sphincter opens. This mechanism is coordinated by the sym-
pathetic fibers and prevents retrograde ejaculation into the bladder.5,7
Given that erection and ejaculation are separate events and that the
neurons responsible for the two events are different, ejaculation can
occur without the presence of an erection and erections can be present
without the ability to ejaculate.
Erectile and ejaculatory function in patients with neurological
damage
The disruption of any of the neural features described above can cause
erectile and/or ejaculatory dysfunction. Therefore, the systems are very
susceptible to neurological damage, with a number of different con-
ditions having the ability to disrupt them.
Erectile dysfunction (ED) is the inability to achieve or maintain an
erection that is sufficiently rigid for achieving satisfying sexual inter-
course 8 and it is either partial or complete depending on the extent of
neurological damage.
Ejaculatory dysfunction may take different forms, including pre-
mature ejaculation, retrograde ejaculation, anejaculation and delayed
ejaculation. The latter three are associatedwith neurological defects. In
retrograde ejaculation, all or part of the ejaculate reaches the bladder
instead of being expelled through the urethral meatus. This condition
is caused by a malfunction in the bladder neck closure secondary to
dysfunction of the sympathetic nerves, which control this mech-
anism.9 Retrograde ejaculation causes the post-ejaculatory urine to
be cloudy and is ultimately diagnosed when sperm are present in the
bladder or urine after ejaculation.10 Anejaculation is a complete lack of
both antegrade and retrograde ejaculate. SCI is the most common
neurological cause of anejaculation.11 Delayed ejaculation is a less
severe condition in which ejaculation can occur at a higher threshold
of stimulation than normally needed.10
NEUROLOGICAL DEFECTS
Surgery/trauma
Both pelvic trauma and pelvic surgery can cause direct damage to the
pelvic floor nerves and disrupt neurological mechanisms responsible
for erection and ejaculation. While prostatectomies and cystectomies
certainly can cause nerve damage, their influence on anejaculation is
due to more than just neurological reasons, as accessory sexual glands
and semen pathways are removed during these surgeries. Rectal sur-
gery can create problems due to damage of the peripheral nerves and to
damage of the superior hypogastric plexus. Thus, ED is seen in 36%–
60% of patients after radical rectal surgery.12 Other types of surgeries
can cause damage to the lumbar sympathetic ganglia, the superior
hypogastric plexus and fibers from both of these structures. These
surgeries include periaortic surgeries, such as aneurism or bypass pro-
cedures, trauma surgery, any retroperitoneal lymph node samplings,
and, in particular, retroperitoneal lymph node dissection in conjunc-
tion with testicular cancer. The classical retroperitoneal lymph node
dissection removes post-ganglionic sympathetic nerves and the hypo-
gastric plexus, which are necessary in normal ejaculation. Nerve-
sparing retroperitoneal lymph node dissection has been developed
to preserve these structures and has shown excellent results.
However, high rates of post-surgical ejaculatory dysfunction are still
evident with high tumor burdens or surgery after chemotherapy.11
Diabetes
Diabetes causes disruption of sexual function via the following two
mechanisms: autonomic neuropathy, which causes ED and ejaculat-
ory dysfunction, and concurrent vascular disease, which is a major
cause of ED.
ED affects 35%–75% of type 1 diabetic males13 and ejaculatory
dysfunction is estimated to be present in approximately 40% of this
group.14 Ejaculatory dysfunction can exhibit a slow progressive decline
from a decreased amount of ejaculate-to-retrograde ejaculation to
anejaculation depending on the degree of sympathetic autonomic
neuropathy involved.14,15 As with other long-term complications of
diabetes, the occurrence of these conditions is related to how well
the patient’s blood sugar is controlled.16
Furthermore, semen volume has been shown to be reduced in
patients with diabetes (both types 1 and 2) compared to normal con-
trols.17–22 Results regarding morphology and motility are conflicting,
even though most studies find one or both of these parameters
reduced.18–20,22 Also, increased spermDNA damage has been detected
in diabetic patients.17 Potential mechanisms behind the altered semen
parameters in diabetic patients include endocrine disruption with
reduced testosterone production and oxidative stress.23 The reduced
semen volume may be caused by neurological damage as atony of the
seminal vesicles has been shown in infertile diabetic patients with
neuropathy.24
Both the sexual dysfunction and the potentially reduced semen
quality can cause infertility. While the topic is still controversial, infer-
tility has been found to bemore prevalent in diabeticmen than in non-
diabetic controls,25 and a recent retrospective analysis has found a high
prevalence of subfertility (51%) among men with diabetes,26 thus
highlighting the possible link between diabetes and infertility.
Congenital spinal abnormalities
Neural tube defects are congenital disorders of the spinal cord. The
lumbar vertebrae are involved in more than 90% of cases, and the
lower thoracic vertebrae in another 5% of cases.27 Most patients with
these conditions have some kind of sexual dysfunction. Surgical treat-
ment of these conditions can be a separate cause of neurological
damage that creates further sexual dysfunction.28 The highest like-
lihood of becoming a father is found in men with lower and less severe
damage.29 Sometimes, patients with lifelong ejaculatory dysfunction
are found to have an occult dysplasia of the lower spinal cord, possibly
with tethered cord syndrome.
MS
MS is a demyelinating disease of unknown etiology that affects the
central nervous system—both the brain and the spinal cord.30 The
course of this condition varies; however, it usually progresses and
increases in severity over time. Its effect on sexual function depends
on the location of plaques in the central nervous system with the
degree of sexual dysfunction not necessarily correlating to the dura-
tion of the condition.31 ED may be present in approximately 73% of
men and ejaculatory dysfunction in about 50% of men with this con-
dition.32 Reduced libido is reported in about 40%.32
Little research has been done to access fertility and the semen quality
of male MS patients. However, a study from 2008 clearly points to
reduced sperm counts, reduced sperm motility and altered sperm
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morphology in MS patients compared to normal controls.33 The
diminished semen quality was particularly pronounced in patients
with progressive disease. Possible explanations for the findings include
a disturbed hypothalamus–pituitary–testis axis with reduced levels of
sex hormones due to neurological damage, as well as reduced hor-
mone production due to chronic inflammation. In addition to sexual
dysfunction and reduced semen quality caused by the disease, MS
patients may have reduced fertility as a consequence of adverse effects
from their treatment.34
SCI
SCI induce a disruption of the nerve supply responsible for erectile
function and ejaculation, which commonly causes both ED and aneja-
culation. Only about 9% of SCI men can ejaculate through mastur-
bation or sexual intercourse.35 In addition, SCI can cause semen
abnormalities in the form of low sperm motility and low sperm viab-
ility.36 Factors in sperm transportation/storage, the seminal plasma,37–39
and the immune system40–45 have recently emerged as the most likely
explanations for these abnormalities. Semen abnormalities are most
likely to occur in SCI men who have complete lesions of the spinal
cord.46 As this condition most often occurs in young men,47–51 fertility
is a major concern for these patients.
Other courses of neurologically induced sexual dysfunction include
various causes of peripheral neuropathy, transverse myelitis and vas-
cular spine injuries.
Management of ED
Success of ED treatment depends on the degree of neurological
damage. The least invasive method, which should be considered first
line, is oral treatment with PDE5 inhibitors. It is a prerequisite that the
patient has some residual nerve function to induce the erection.
Therefore, the treatment is generally best in the early stages of pro-
gressive neurological disorders when only partial neurological damage
is present. PDE5 inhibitors were shown to be effective in approxi-
mately 50% of diabetic men.52 In a small (n58) non-randomized
study investigating spina bifida patients, 63% had improved erections
with treatment.53 Also, men with SCI may benefit considerably from
PDE5 inhibitor treatment.54–56
The second line therapy—which is often necessary in neurological
disorders—is penile injection therapy in which vasoactive agents are
injected into the cavernous tissue of the penis. This activates the cyclic
adenosinemonophosphate system and leads to calcium efflux, smooth
muscle relaxation and an erectile response. Alprostadil, papaverine
and phentolamine can be used for this purpose and the treatment
has been shown to be effective in a number of neurological conditions,
including MS, diabetes and SCI.57–61 It is important to note that in
men with SCI, the denervated tissue tends to be very sensitive to
intracavernous injection. This means that the treatment has a success
rate of up to 95% and also that the risk of priapism is increased.60,61
Therefore, SCI patients should generally be treated with lower doses
than non-SCImen. Intraurethral alprostadil can be attempted if injec-
tion therapy is unacceptable to the patient; however, this method is
generally less effective.62
Vacuum constriction devices can also be used based on patient
preference. These devices induce a negative pressure that pulls venous
blood into the penis. A constriction band is then placed at the base of
the penis to keep the blood there. Vacuum devices can cause discol-
oration of the penis, decrease in penile temperature, discomfort with
ejaculation and reduced penile sensation, but for some patients, the
method can be a satisfactory choice. This treatment has been shown to
be effective in 75% of diabetic men and in 72%–93% of SCI men.63–66
In SCI men with reduced penile sensation, it is important to be aware
of potential ischemic complications with prolonged use of vacuum
devices.67
The third-line treatment for ED is penile implants, which can be
rigid, semirigid and inflatable. Three-piece inflatable devices, consist-
ing of two cylinders, a reservoir and a pump in the scrotum, are the
most commonly used. Simpler devices can sometimes be an advantage
in patients with decreased hand function, such as with some SCI
patients. Penile implants may provide a benefit in keeping condom
catheters in place, as well as provide stability for intermittent cathe-
terization in SCI patients. Overall, the satisfaction rates are high and
the complication rates are low with penile implants. However, infec-
tion rates are higher in diabetics than in the general patient popu-
lation,68 and both infection rates and the number of mechanical
failures are increased in SCI men.69,70 These problems should be con-
sidered carefully prior to inserting an implant.
MANAGEMENT OF EJACULATORY DISORDERS
Retrograde ejaculation
The initial management of retrograde ejaculation depends on the
degree of neurological damage. The least invasive treatment consists
of medications that can sometimes reverse the retrograde ejacu-
lation.71 Sympathomimetic agents are used since they can induce a
pharmacological stimulation of the receptors that are not being sti-
mulated by normal neurological mechanisms. These agents cause a
contraction of the bladder neck, which prevents the ejaculate from
flowing into the bladder. These agents include imipramine, ephedrine,
pseudoephedrine and phenylpropanolamine.11,71,72 Pharmacological
treatment generally works best in the early stages of progressive neuro-
logical disorders, such as diabetes,72 or in incomplete peripheral
lesions as can be seen after surgery or trauma. If the malfunction of
the ejaculatory reflex is complete, as seen with SCI men, medications
will, of course, have little effect. Drug treatment should be adminis-
tered only around the time of ovulation in order to avoid unnecessary
side effects.71
If the retrograde ejaculation cannot be reversed by drugs, the next
step is post-ejaculation bladder harvest of sperm. Both urine and the
acidic environment in the bladder can damage sperm;73 thus, the
bladder must be emptied prior to ejaculation. This is done by cathe-
terization in which a sperm-friendly medium (e.g., sperm wash med-
ium or Ham’s F-10 medium) is also installed in the bladder.74 When
ejaculation has taken place, the sperm are collected immediately—
again by catheterization.Here, it is important to use a non-spermicidal
lubricant and a plastic catheter, because sperm can adhere to silicone
catheters. The sperm are then processed in order to be used in assisted
reproductive procedures.75–77
Anejaculation
As with retrograde ejaculation, anejaculation caused by mild neuro-
logical disorders can sometimes be treated with sympathomimetic
agents.11,71,72 Inmore serious disorders, assisted ejaculation consisting
of penile vibratory stimulation (PVS) or electroejaculation (EEJ) can
be employed. If these procedures fail, surgical sperm retrieval can be
attempted.
ASSISTED EJACULATION
PVS
In PVS, a vibrator is used to mechanically induce an ejaculation in SCI
men. The only commercially available device for PVS is the FERTI
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CARE vibrator (Multicept A/S, Frederiksberg, Denmark) that was
developed for this purpose (Figure 1). It is important that stimulation
be done with an exact amplitude and frequency (2.5 mm and 100 Hz
respectively).78 The device is placed on the glans penis through which
it activates the dorsal nerve of the penis, which, as previously
described, constitutes the afferent limb of the ejaculatory reflex.
This, in turn, activates the efferent part of the reflex via the spinal cord
and an antegrade ejaculation is initiated.79,80 PVS is then terminated
and the ejaculate is collected in a non-spermicidal cup. The urethra is
milked manually to retrieve as many sperm cells as possible.
It follows that both the afferent and efferent limbs of the reflex must
be functioning for PVS to be successful. Because of this, men with SCI
above the level of the reflex (meaning above T10) have an 88% success
rate with PVS, whereas men with lower injuries below this level have
only a 15% success rate.81,82 Disruption of the dorsal penile nerves
terminates the reflex response.83 Finally, cortical inhibition can pre-
vent the reflex response, which is the primary reason that this proced-
ure is not feasible for all patients with neurological conditions. The
best candidates for PVS are SCI men with complete lesions. Non-SCI
patients receive limited benefits from this device.
When successful, PVS will usually induce an ejaculation within the
first 2min of stimulation.84 If this does not occur, subsequent attempts
are made following a brief interruption of stimulation. Adverse reac-
tions are rare, but given that patients with reduced or absent sensation
of the glans may not notice bruises or abrasions from the stimulation,
the skin should be inspected both before treatment and during breaks.
Treatment should be withheld or performed very carefully when there
is inflammation or severe irritation of the glans penis. If PVS is initially
unsuccessful, an attempt to use two vibrators simultaneously85 or to
use accessory abdominal electrical stimulation86 can be made. Oral
administration of midodrine or a PDE5 inhibitor prior to PVS may
also be beneficial.87–89 Patients are generally considered non-respon-
ders after two failed PVS attempts, at least 1 week apart, in which at
least the two-vibrator technique has been attempted. However,
patients with a recent injury may not respond readily due to the spinal
shock phase andmore attempts can be made usually 1–6 months after
the injury.
Aside from the rare incidence of skin irritation from prolonged
stimulation, PVS must be performed with caution in patients with a
penile implant, as the vibrator may push the glans onto the implant.
More importantly, PVS should not be administered to patients with
severe cardiac disease or untreated hypertension because the proced-
ure can cause a rise in blood pressure.88
Finally, PVS can induce an uninhibited sympathetic reflex response
in patients with an injury at the T6 level or above.90 This reflex res-
ponse creates a condition called autonomic dysreflexia (AD), which
begins with presymptoms in the form of hypertension, headache,
flushing and bradycardia and can result in stroke, seizure and death.
Patients who are prone to this condition will usually have experienced
symptoms of an increased blood pressure in response to unpleasant
stimuli below the level of their injury. In all patients, the physician
should be aware of steep increases in blood pressure and presymptoms
during stimulation. In patients assessed to be at risk of developing AD,
sublingual nifedipine, 20 mg, should be administered approximately
15 min prior to stimulation, as this can limit the increase in blood
pressure. In subsequent PVS attempts, the dose can be adjusted based
on the patient’s response.91–93 If presymptoms occur or if the patient’s
blood pressure is noted to rise dramatically during PVS, the stimu-
lation should be discontinued and the patient should be returned to an
upright position.
EEJ
EEJ is a method in which an electrical current is used to induce
ejaculation. This method is feasible with both SCI patients and with
patients who have other causes of neurological anejaculation. The only
Food and Drug Administration (FDA)-approved device for this pro-
cedure is the Seager Model 14 Electroejaculator (Dalzell Medical
Systems, The Plains, VA, USA) (Figure 2). Ejaculation is induced by
placing the patient in a lateral decubitus position and inserting the
probe into the rectum with the electrodes facing the seminal vesicles
and the prostate. The electrical current is then delivered in a wave-like
pattern with 5 s of stimulation followed by rest periods of approxi-
mately 20 s, during which ejaculation can occur. This often happens in
a non-projectile, dribbling fashion and the ejaculate is collected during
the procedure. It is important to milk the urethra to retrieve as much
semen as possible. The first wave starts with 5 V and, in subsequent
waves, voltage is progressively increased by 1–5 V until a maximum of
20–30 V is reached. Following each wave, the current is abruptly dis-
continued because this has been shown to increase the antegrade frac-
tion of the ejaculate.94,95 The ejaculatory reflex is most likely activated
by muscular contractions that are induced by the electricity.94
Stimulation is delivered until ejaculation is no longer induced—an
Figure 1 The FERTI CARE vibrator (Multicept A/S, Frederiksberg, Denmark)
activates the ejaculatory reflex trough mechanical stimulation. The device allows
for amplitude and frequency to be set at exactly 2.5 mm and 100 Hz. This is
essential in inducing ejaculation in SCI men. SCI, spinal cord injury.
Figure 2 The Seager model 14 electroejaculator (Dalzell Medical Systems, The
Plains, VA, USA) induces ejaculation by means of an electric current. This is done
trough a rectal probe. The device has a built in thermometer to monitor rectal
temperature during stimulation.
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indication that the system is empty. Up to 20 waves of stimulationmay
be necessary. Stimulation is of course stopped if the patient does not
tolerate the procedure. Also, the Seager device has a built-in ther-
mometer that will terminate the procedure if the rectalmucosa reaches
a temperature above 38.5 uC.
EEJ is generally safe and is extremely effective in inducing ejaculation
with a success rate of almost 100% in patients who can accept the
procedure.81 However, it is more invasive, more demanding and more
expensive than PVS, and it is less preferred by patients.96 EEJ always
requires administration by a physician and both before and after the
procedure rectoscopy must be performed to rule out any possible
mucosal lesions. Also, SCI men with incomplete lesions and/or with
preserved pelvic sensation as well as patients with other neurological
conditions require general anesthesia during the procedure.97,98
Finally, EEJ usually results in a lower total motile sperm count than
PVS96,99 and there is often a significant amount of retrograde ejacu-
lation after which sperm must be collected as described previously.
In the largest case series of its kind, EEJ was performed 953 times in
210 SCI patients for an average of 4.5 trials per patient. Altogether 897 of
the 953 EEJ trials (94.1%) resulted in ejaculation and in about 90% of
cases the ejaculate contained spermatozoa which could be used for either
a simple insemination procedure or one of the more complicated assisted
reproductive techniques (ARTs, see below).35 When a second trial of EEJ
was attempted after a finding of azoospermia on the first attempt, the
second EEJ resulted in semen with sperm in a third of the patients.100
Contraindications of EEJ include lesions/inflammation of the rec-
tum and bleeding disorders aswell as anticoagulation therapy. As EEJ’s
effects on pacemakers are unknown, these are a relative contraindica-
tion. As with PVS, EEJ can cause AD in patients with an injury at or
above T6. This condition is prevented by pre-treatment with nifedi-
pine as described above. Also, patients undergoing EEJ must be mon-
itored carefully and monitoring of blood pressure in patients under
general anesthesia is an absolute requirement.
Surgical sperm retrieval methods
If sperm cannot be obtained with assisted ejaculation, then sperm
retrieval can be attempted either by aspiration or through surgical
exploration. These are invasive procedures in which sperm are col-
lected directly from the epididymis or from the testis. Sperm
retrieval methods were developed to retrieve sperm from azoosper-
mic men and should generally not be the first choice in anejacula-
tion, as both PVS and EEJ are cheaper, less invasive, and result in a
higher motile sperm count. At least in SCI men, it may even be
reasonable to obtain a second ejaculate by EEJ in men who are
azoospermic on their first ejaculate before proceeding to sperm
retrieval, as the second ejaculate will sometimes contain live sper-
matozoa.100 However, in neurological anejaculation, which is
refractory to assisted ejaculation, it may be necessary to employ
surgical procedures. The procedures include percutaneous sperm
aspiration from either the epididymis or the testis, and surgical
sperm retrieval either by conventional or microsurgical means.
The details of these methods are described in separate chapters.
The procedures sometimes result in hematomas and pain, while
serious complications, including injury to the arteries and partial
testicular infarction or permanent testicular devascularization, are
rare.101,102 Sperm obtained from sperm retrieval methods are
employed in ARTs. This can be done immediately after extraction
or the sperm can be cryopreserved and used at a later time. The latter
can potentially spare the patient from repeated surgeries and may
avoid hormonal treatment of the female if no sperm can be retrieved.
Choice of assisted ejaculation/sperm retrieval technique
Asmentioned previously, the first choice in neurological anejaculation
should be assisted ejaculation. The more expensive and more invasive
procedures of aspiration and surgery should only be used if both PVS
and EEJ have failed. In an analysis of 3152 procedures in 500 SCI men,
ejaculates were obtained with either PVS or EEJ in 97% of patients.
The total motile sperm counts exceeded five million in 63% of cases.35
Because of lower cost, less invasiveness and a higher total motile sperm
outcome than with EEJ, PVS is the first choice in SCI men and should
always be attempted. Patients with other conditions, such as diabetes
or MS, can benefit from EEJ under general anesthesia.
To the possible detriment of their patients, many practitioners are,
however, omitting the assisted ejaculatory techniques and use surgical
procedures as the first-line treatment.81 This ismost likely due to a lack
of knowledge and/or training regarding PVS and EEJ. Clinics that are
not able to offer these treatments should, as a minimum, inform their
patients of the option of PVS/EEJ and refer them upon request.
With a healthy female partner, the relative success rates, including
time to pregnancy, with PVS and EEJ, depends on the total motile
sperm count obtained and the ART chosen. SCI patients (in whom
PVS/EEJ are most often performed) can benefit from the same repro-
ductive techniques as other infertile couples with similar pregnancy
rates.81
ARTs
When sperm have been obtained—either from assisted ejaculation or
from sperm retrieval methods—ARTs follow.
Methods include intravaginal insemination (IVI), intrauterine
insemination (IUI) and in vitro fertilization (IVF)/intracytoplasmic
sperm injection (ICSI). Assuming only a male factor in the couples’
infertility, the choice of ART is made based on the total motile sperm
count. If there are more than four million (and especially above 10
million) motile sperm, the simple and low-cost methods of IVI and
IUI can be attempted.103,104 This is especially feasible after sperm have
been harvested in retrograde ejaculation and when assisted ejaculatory
procedures are used to obtain sperm.With lower numbers of sperm or
after IVI/IUI failures, the more invasive and expensive techniques of
IVF with or without ICSI are used. With surgical sperm retrieval
methods, the motile sperm counts obtained are usually so low that
they force the couple to start with IVF/ICSI.
IVI
IVI is a method in which PVS and self-insemination are combined in a
fashion that allows couples with an SCI male partner to perform the
insemination themselves in their own home. The treatment starts in
the clinic where the feasibility of PVS is evaluated and the man is
examined. If ejaculation is induced, the risk of AD is manageable
and sufficient numbers of motile sperm are found in the ejaculate,
IVI can be offered. The patient and/or his partner are then instructed
in PVS and they obtain a PVS device to use at home. Here, the time of
ovulation is monitored by basal body temperature or urinary-luteiniz-
ing hormone excretion kits. At that time, the ejaculate is collected in a
non-spermicidal cup and injected into the vagina of the female partner
with a needleless syringe.79 IVI studies have reported pregnancy rates
of 25%–65% per couple.105–110
IUI
IUI is very similar to IVI, but is performed at the clinic. Here, semen is
collected by PVS or EEJ. If indicated, spermmay also be retrieved from
the bladder after retrograde ejaculation. Processing then takes place to
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isolate the most motile sperm.111 The sperm are injected into the
uterine cavity, which bypasses the cervix so that a larger number of
sperm reach the fallopian tubes, but the sperm must still be motile to
reach the oocyte,112 The injection is done at the time of ovulation,
which is sometimes induced by human chorionic gonadotropin.
Giving the female partner fertility drugs, such as anti-oestrogens or
gonadotrophins, is termed ovarian stimulation and can increase the
number of available oocytes,113 However, it is controversial whether
this treatment improves IUI pregnancy rates in isolated male infertil-
ity114,115 and it carries a risk of ovarian hyperstimulation syndrome
and causes an increased rate of multiple pregnancies, which raises the
perinatal mortality and the maternal morbidity.116–120
There are no general data on IUI success in patients with neuro-
logical ejaculatory dysfunction; however, IUI in couples with SCImale
partners has resulted in pregnancies for approximately one in three
couples. The total motile sperm count is the most important predict-
ive factor.104,105,107,109,110
IVF/ICSI
IVF/ICSI always involves ovarian stimulation and a human chorionic
gonadotropin administration to trigger ovulation. Oocytes are then
retrieved transvaginally under the guidance of ultrasound. In simple
IVF, the sperm and oocytes are mixed in Petri dishes where fertiliza-
tion can occur. With ICSI, a single sperm is injected directly into the
oocyte. This means that ICSI allows fertilization with very few non-
functional sperm whereas IVF relies on adequate gamete interaction
and oocyte penetration.121–123 After about 5 days of in vitro develop-
ment, embryos are injected into the uterus for implantation.124
Again, there are no data on success rates for these methods in
neurological patients in general. IVF and ICSI in couples with SCI
male partners have shown pregnancy rates between 38% and 100%
per couple.105–109,125–127
It is important to remember that IVF and ICSI procedures are
invasive and costly, compared to IVI/IUI. Maternal risks include
potential complications with oocyte retrieval, and the ovarian stimu-
lation related risks mentioned previously.
Psychological aspects
While infertility is typically treated as a medical diagnosis that may be
overcome using the various procedures outlined previously, the psy-
chological impact of the inability to conceive naturally is often
neglected.
An infertility diagnosis can have a negative impact on the psycho-
logical health of patients, both male and female, given that the dia-
gnosis is often accompanied by a major change in lifestyle due to an
increased number of medical appointments, the possibility of recur-
ring medical procedures and a number of other issues involved in
fertility treatments.128 While this impact is often more stressful for
women than men,129–131 an increase in mood disorders, including
depression, has been evident for both sexes.128,132
A recent review128 notes the under-representation of literature
available regarding the psychological impact of infertility diagnoses
on men’s psychological health.
Even less is known regarding how infertility affects males within the
populations discussed in this review. An editorial in Sexuality and
Disability 133 discussed both the medical and the psychosocial issues
related to having an SCI and fertility, noting the importance of addres-
sing both of these needs in patients and of being knowledgeable
regarding recent innovations in fertility treatments. Also of import-
ance is the negative impact that emotional issues can have on being
able to conceive, with psychological stress being listed as a common
reason for discontinuing fertility treatments.128,134
A study135 examined the psychological impact of an infertility dia-
gnosis on war veterans, who had sustained SCI during the Iran–Iraq
war, as compared to otherwise healthy infertile controls. Both groups
showed negative psychological effects that may have been due to their
fertility status, including anxiety and depression, as compared to rates
in the normal population. Interestingly, the finding that the partners
of the otherwise healthy infertile males reported being more anxious
regarding the duration of infertility than the partners of the SCI males
may provide insight into differences in the coping mechanisms
between these groups. Infertility is typically a hidden disorder, in that
its symptoms are not obvious until a couple attempts to conceive and
is unsuccessful. In clinical groups, such as patients with an SCI or that
have undergone trauma or surgeries, the knowledge that conception
may not be natural and will require the use of fertility treatments may
help psychologically prepare both the patient and his or her partner for
the inevitable number of clinical visits associated with fertility treat-
ments, as well as protect against the stressful nature of fertility cycles
including the failure to conceive. This is not to say that SCI couples do
not experience the negative mental strain that accompanies infertility
as other infertile couples do; however, it does suggest that the psycho-
logical experience of infertility may differ when there is prior know-
ledge that the likelihood of conceiving naturally is low. Future studies
are needed in order to gain a greater understanding of the psycho-
logical impact of infertility.
CONCLUSION
Neurological disorders can cause infertility through ED and ejaculat-
ory dysfunction which can potentially cause severe psychological
stress. However, several methods are available to help these patients
father children. Methods to retrieve sperm include medications and/
or bladder harvest for retrograde ejaculation, as well as PVS, EEJ and
several surgical sperm retrieval methods for anejaculation. These
methods are combined with IVI and ARTs to produce high pregnancy
success rates. The choice of both sperm retrieval and reproductive
technique depends on the underlying neurological condition and
the total motile sperm count. It is important to consider the individual
patient and to opt for the most non-invasive and cost-effective treat-
ments first.
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